Patent · US Active

Pharmaceutical composition, methods for treating and uses thereof

US11833166B2 · kind B2 · utility

2Cited by

77References

24Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Uli Christian BROEDL · Oakville, CA
Sreeraj MACHA · Berkeley Heights, US
Maximilian von EYNATTEN · Wiesbaden, DE
Hans-Juergen WOERLE · Munich, DE

Key dates

Filing date	Jun 10, 2021
Grant date	Dec 5, 2023
Priority date	—
Expiry date	Dec 4, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P13/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing metabolic disorders, such as type 1 or type 2 diabetes mellitus or pre-diabetes, in patients with renal impairment or chronic kidney disease (CKD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.